Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis

被引:8
|
作者
Khurana, Arushi [1 ]
Dalland, Joanna C. [2 ]
Young, Jason R. [3 ]
Inwards, David J. [1 ]
Paludo, Jonas [1 ]
机构
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Div Hematopathol, Dept Lab Med & Pathol, Rochester, MN USA
[3] Mayo Clin, Dept Radiol, Div Nucl Med, Rochester, MN USA
关键词
OUTCOMES;
D O I
10.1002/ajh.26233
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E298 / E301
页数:4
相关论文
共 50 条
  • [1] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
    Mian, Agrima
    Hill, Brian T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
  • [2] Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
    Chong, Elise A.
    Chong, Emeline R.
    Therwhanger, Dylan
    Nasta, Sunita D.
    Landsburg, Daniel J.
    Barta, Stefan K.
    Svoboda, Jakub
    Gerson, James N.
    Ghilardi, Guido
    Paruzzo, Luca
    Fraietta, Joseph A.
    Weber, Elizabeth
    Stefano, Natalie
    Porter, David L.
    V. Frey, Noelle
    Garfall, Alfred L.
    Ruella, Marco
    Schuster, Stephen J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (07): : 726e1 - 726e8
  • [3] Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma
    Marchetti, M.
    Visco, C.
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1442 - 1450
  • [4] Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
    Aydilek, Enver
    Klein-Scory, Susanne
    Thomson, Julia
    Nilius-Eliliwi, Verena
    Vangala, Deepak
    Schroers, Roland
    Wulf, Gerald
    Mika, Thomas
    HEMASPHERE, 2023, 7 (09):
  • [5] Bridging Radiotherapy prior to Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma
    Fetooh, A.
    Lionel, A.
    Fang, P.
    Nze, C. C.
    Ahmed, S.
    Westin, J.
    Flowers, C.
    Pinnix, C. C.
    Dabaja, B.
    Gunther, J. R.
    Neelapu, S. S.
    Wang, M. L.
    Jain, P.
    Wu, S. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E622 - E623
  • [6] Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Villacampa, Guillermo
    van Doesum, Jaap A.
    Chiappella, Annalisa
    Bonifazi, Francesca
    Lopez-Corral, Lucia
    van Aalderen, Michiel
    Kwon, Mi
    Martinez-Cibrian, Nuria
    Bramanti, Stefania
    Luis Reguera-Ortega, Juan
    Camacho-Arteaga, Lina
    Schmidt, Christian
    Marin-Niebla, Ana
    Jose Kersten, Marie
    Martin Garcia-Sancho, Alejandro
    Zinzani, Pier Luigi
    Corradini, Paolo
    van Meerten, Tom
    Subklewe, Marion
    Barba, Pere
    BLOOD ADVANCES, 2022, 6 (12) : 3606 - 3610
  • [7] Real-World Evidence of Brexucabtagene Autoleucel for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Camacho, Lina
    Chiappella, Annalisa
    Guadagnuolo, Serafina
    Lopez Corral, Lucia
    Bastos-Oreiro, Mariana
    Delgado Serrano, Javier
    Schmidt, Christian
    Carpio, Cecilia
    Luis Reguera, Juan
    Kwon, Mi
    Martin Garcia-Sancho, Alejandro
    Luigi Zinzani, Pier
    Corradini, Paolo
    Subklewe, Marion
    Barba, Pere
    BLOOD, 2021, 138
  • [8] Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy
    Jain, Preetesh
    Nastoupil, Loretta
    Westin, Jason
    Lee, Hun Ju
    Navsaria, Lucy
    Steiner, Raphael E.
    Ahmed, Sairah
    Moghrabi, Omar
    Oriabure, Onyeka
    Chen, Wendy
    Badillo, Maria
    Flowers, Christopher R.
    Wang, Michael L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (02) : E38 - E42
  • [9] Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma
    Tempescul, Adrian
    Ianotto, Jean-Christophe
    Morel, Frederic
    Marion, Veronique
    De Braekeleer, Marc
    Berthou, Christian
    ANNALS OF HEMATOLOGY, 2009, 88 (09) : 921 - 922
  • [10] Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma
    Adrian Tempescul
    Jean-Christophe Ianotto
    Frederic Morel
    Veronique Marion
    Marc De Braekeleer
    Christian Berthou
    Annals of Hematology, 2009, 88 : 921 - 922